Your browser doesn't support javascript.
loading
Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration.
Simon, Germain; Favresse, Julien; Gillot, Constant; Closset, Mélanie; Catry, Émilie; Dogné, Jean-Michel; Douxfils, Jonathan; Wieërs, Grégoire; Bayart, Jean-Louis.
  • Simon G; Department of Laboratory Medicine, Clinique St-Pierre, Ottignies, Belgium.
  • Favresse J; Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.
  • Gillot C; Department of Pharmacy, Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium.
  • Closset M; Department of Pharmacy, Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium.
  • Catry É; QUALIblood SA, Namur, Belgium.
  • Dogné JM; QUALIblood SA, Namur, Belgium.
  • Douxfils J; Department of Pharmacy, Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium.
  • Wieërs G; Department of Pharmacy, Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium.
  • Bayart JL; QUALIblood SA, Namur, Belgium.
Clin Chem Lab Med ; 61(10): 1875-1885, 2023 09 26.
Article en En | MEDLINE | ID: mdl-37078220
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article